http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: the combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies
van Tilburg, C. M. (First author)DKFZ* ; Witt, R.DKFZ* ; Heiss, M.DKFZ* ; Pajtler, K. W.DKFZ* ; Plass, C.DKFZ* ; Poschke, I.DKFZ* ; Platten, M.DKFZ* ; Harting, I. ; Sedlaczek, O.DKFZ* ; Freitag, A.DKFZ* ; Meyrath, D. ; Taylor, L. ; Balasubramanian, G. P.DKFZ* ; Jäger, N.DKFZ* ; Pfaff, E.DKFZ* ; Jones, B. C.DKFZ* ; Milde, T.DKFZ* ; Pfister, S. M.DKFZ* ; Jones, D. T. W.DKFZ* ; Kopp-Schneider, A.DKFZ* ; Witt, O. (Last author)DKFZ*
2020
Springer
Heidelberg
This record in other databases:

Please use a persistent id in citations: doi:10.1186/s12885-020-07008-8
Note: #EA:B310#LA:B310#
Contributing Institute(s):
- KKE Pädiatrische Onkologie (B310)
- DKTK HD zentral (HD01)
- B062 Pädiatrische Neuroonkologie (B062)
- Epigenomik (B370)
- Neuroimmunologie und Hirntumorimmunologie (D170)
- E010 Radiologie (E010)
- C060 Biostatistik (C060)
- Pediatric Glioma (B360)
Research Program(s):
- 312 - Functional and structural genomics (POF3-312) (POF3-312)
Appears in the scientific report
2020
Database coverage:
;

;

; Article Processing Charges ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; DOAJ Seal ; Ebsco Academic Search ; Essential Science Indicators ; Fees ; IF < 5 ; JCR ; NCBI Molecular Biology Database ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection